메뉴 건너뛰기




Volumn 37, Issue SUPPL. 1, 1997, Pages

Appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine: Current perspectives

Author keywords

dihydroergotamine (DHE); ergot; ergotamine tartrate (ET); migraine; practice parameters

Indexed keywords

DIHYDROERGOTAMINE; ERGOTAMINE TARTRATE; SUPPOSITORY BASE;

EID: 0031024923     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper
Times cited : (14)

References (3)
  • 1
    • 0029049743 scopus 로고
    • Practice parameter: Appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus
    • Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus (summary statement). Neurology. 1995;45:585-587.
    • (1995) Neurology , vol.45 , pp. 585-587
  • 2
    • 0029078085 scopus 로고
    • Safety and efficacy of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus
    • Silberstein SD, Young WB. Safety and efficacy of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus. Neurology. 1995;45:577-584.
    • (1995) Neurology , vol.45 , pp. 577-584
    • Silberstein, S.D.1    Young, W.B.2
  • 3
    • 0029120324 scopus 로고
    • Migraine symptoms: Results of a survey of self-reported migraineurs
    • Silberstein SD. Migraine symptoms: results of a survey of self-reported migraineurs. Headache. 1995;35:387-396.
    • (1995) Headache , vol.35 , pp. 387-396
    • Silberstein, S.D.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.